Trials / Conditions / Extrapulmonary Neuroendocrine Carcinoma
Extrapulmonary Neuroendocrine Carcinoma
3 registered clinical trials studyying Extrapulmonary Neuroendocrine Carcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NEC NCT07510594 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Not Yet Recruiting | Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previ NCT07328490 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Not Yet Recruiting | Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cance NCT07509034 | National Cancer Institute (NCI) | Phase 1 |